Abstract
It is controversial whether the cardiac type-2 ryanodine receptor harboring a catecholaminergic polymorphic ventricular tachycardia-associated point mutation is regulated by luminal or cytosolic Ca(2+). This commentary discusses new findings supporting the cytosolic Ca(2+)-dependent regulation.